Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Aug 31, 2025 | (Q4)Aug 31, 2025 | (Q3)May 31, 2025 | (Q2)Feb 28, 2025 | (Q1)Nov 30, 2024 | (FY)Aug 31, 2024 | (Q4)Aug 31, 2024 | (Q3)May 31, 2024 | (Q2)Feb 29, 2024 | (Q1)Nov 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -25.45%-1.09M | -119.82%-197.73K | -213.25%-274.08K | -8.17%-277.72K | 21.73%-339.83K | -9.71%-868.33K | 61.93%-89.95K | 26.69%-87.5K | -164.86%-256.74K | -28.09%-434.14K |
| Net income from continuing operations | -31.77%-2.84M | 69.48%-161.17K | -167.40%-966.35K | -60.93%-1.37M | 17.56%-341.2K | -20.68%-2.16M | 41.45%-528.06K | -79.13%-361.38K | -665.25%-853.21K | 27.62%-413.9K |
| Operating gains losses | 3,849.39%25.83K | 100.01%1 | --0 | -396.25%-6.55K | 210.22%32.38K | -94.10%654 | -284.95%-13.27K | -75.94%1.27K | 167.35%2.21K | 570.56%10.44K |
| Depreciation and amortization | --0 | --0 | --0 | --0 | --0 | -77.42%3.83K | --0 | --0 | -83.76%683 | -51.47%3.15K |
| Asset impairment expenditure | ---- | ---- | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Remuneration paid in stock | 6.71%800.14K | -226.31%-175.55K | -98.42%1.01K | 84.84%958.32K | -41.86%16.37K | 62.52%749.8K | -63.53%138.98K | 108.79%64.2K | 2,817.49%518.47K | -11.45%28.15K |
| Other non cashItems | 817.77%71.78K | --14.93K | --15.62K | -94.89%26.47K | -41.33%14.76K | 92.09%-10K | --0 | --0 | 615.47%518.08K | 8,144.92%25.15K |
| Change In working capital | 57.13%854.68K | -60.29%124.06K | 224.18%675.64K | 36.27%115.97K | 1.61%-60.98K | -13.36%543.94K | 3.93%312.39K | 382.71%208.42K | -2.73%85.11K | -131.53%-61.98K |
| -Change in receivables | 429.04%7.13K | 90.51%-1.09K | -72.31%1.99K | -15.09%7.6K | 79.88%-1.37K | -118.42%-2.17K | -109.30%-11.47K | 123.76%7.18K | 117.30%8.95K | 76.95%-6.83K |
| -Change in prepaid assets | -291.72%-88.92K | -669.51%-74.21K | 193.04%30.75K | -243.57%-58.16K | -50.95%12.7K | 182.08%46.38K | 146.48%13.03K | -15.95%-33.06K | 903.63%40.51K | 409.81%25.89K |
| -Change in payables and accrued expense | 34.18%686.48K | -35.86%199.36K | 66.48%392.89K | 245.16%166.53K | 13.39%-72.31K | -14.66%511.6K | 141.32%310.83K | 124.08%236K | -66.56%48.25K | -137.76%-83.48K |
| -Change in other working capital | 2,204.20%250K | --0 | ---- | ---- | ---- | -116.27%-11.88K | --0 | ---1.72K | ---12.61K | --2.44K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -25.45%-1.09M | -119.82%-197.73K | -213.25%-274.08K | -8.61%-278.86K | 21.99%-338.69K | -9.71%-868.33K | 61.93%-89.95K | 26.68%-87.5K | -164.81%-256.74K | -28.09%-434.14K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | |||||||
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 28.74%1.11M | 0 | 0 | 0 | 44.74%1.11M | 101.82%859.48K | 125K | 0 | -30K | 764.48K |
| Net issuance payments of debt | 3,350.00%975K | --0 | --0 | --0 | --975K | ---30K | --0 | --0 | ---30K | --0 |
| Net common stock issuance | --0 | --0 | --0 | --0 | --0 | 79.51%764.48K | --0 | --0 | --0 | --764.48K |
| Proceeds from stock option exercised by employees | --131.5K | --0 | --0 | --0 | --131.5K | --0 | --0 | --0 | --0 | --0 |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | --125K | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 28.74%1.11M | --0 | --0 | --0 | 44.74%1.11M | 101.82%859.48K | --125K | --0 | ---30K | --764.48K |
| Net cash flow | ||||||||||
| Beginning cash position | -7.99%101.9K | 373.85%316.78K | 282.81%590.86K | 97.17%869.72K | -7.99%101.9K | -76.99%110.75K | -80.74%66.85K | 281.19%154.35K | 218.14%441.09K | -76.99%110.75K |
| Current changes in cash | 293.77%17.15K | -664.16%-197.73K | -213.25%-274.08K | 2.75%-278.86K | 132.43%767.82K | 97.61%-8.85K | 114.83%35.05K | -128.54%-87.5K | -192.13%-286.74K | 196.42%330.34K |
| End cash Position | 16.82%119.05K | 16.82%119.05K | 373.85%316.78K | 282.81%590.86K | 97.17%869.72K | -7.99%101.9K | -7.99%101.9K | -80.74%66.85K | 281.19%154.35K | 218.14%441.09K |
| Free cash from | -25.45%-1.09M | -119.82%-197.73K | -213.25%-274.08K | -8.61%-278.86K | 21.99%-338.69K | -9.71%-868.33K | 61.93%-89.95K | 26.68%-87.5K | -164.81%-256.74K | -28.09%-434.14K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.